Back to search

Peptide record

TPDB43055

AtMP1 Anticancer standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43055
AtMP1
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 24-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
THPPTTTTTTTTTTTTTAAPATTT
Physicochemical Analysis
C98H164N26O42
RNDCEQGILKMFSWYV
T
2378.53
7.85
1
0
3
+0
4.18
-0.604
12.50
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
17
Residue Composition
number
3
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
0
I
0
L
0
K
0
M
0
F
3
P
0
S
17
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 3 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 0 L: 0 K: 0 M: 0 F: 0 P: 3 S: 0 T: 17 W: 0 Y: 0 V: 0
Chemical Descriptors
24
C98H164N26O42
2378.53
7.85
+0
4.18
-0.604
Free
L
Linear
Free
Antimicrobial and Anticancer
Anabastestudineus skin mucus fraction 2
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 8.25 ± 0.14 µg/ml
Anticancer
8.25

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 9.35 ± 0.25 µg/ml
Anticancer
9.35

Target

Breast Cancer
MDA-MB-231
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021